A new test that utilizes zebrafish embryos to screen plastics, composites and polymers for toxicity in medical device manufacturing developed by Microtest Laboratories will be featured at AMI’s Medical Grade Polymer 2013 technical conference in September. “The U.S. Food and Drug Administration (FDA) requires testing to assess medical device toxicology and describes which situations may trigger the need for manufacturers to repeat testing or undertake new programs. The dynamics of such testing are rapidly evolving,” according to a news release from Steven Richter, Ph.D., president and scientific director of Microtest Laboratories and a former FDA official.